Regression of established tumors and metastases by potent vascular endothelial growth factor blockade
Jianzhong Huang, Jessica J. Kandel(Presbyterian College), Darrell J. Yamashiro(Morgan Stanley Children's Hospital), Stephanie M. Zabski(Regeneron (United States)), Angela Kadenhe(Regeneron (United States)), Jocelyn Holash(Regeneron (United States)), Akiko Yokoi(Kobe Children's Hospital), Anna Serur, George D. Yancopoulos(Regeneron (United States)), Kathleen O’Toole(Regeneron (United States)), John S. Rudge(Regeneron (United States)), Jason S. Frischer, Tamara New(Columbia University), Kimberly W. McCrudden(Regeneron (United States))
Cited by 225
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k
Regulation of the Germinal Center Response by MicroRNA-155
|Science|2007|1.5k
Angiopoietin-1 protects the adult vasculature against plasma leakage
|Nature Medicine|2000|1.3k